Skip to content

Device Identifies Specific Details of Your Prescribed Drugs

Understanding medication distinctions is crucial for individuals on multiple medications. Often, pills can be misidentified, particularly when they share similar colors and sizes. Even...

Device Identifies Specific Aspects of Your Prescribed Medications
Device Identifies Specific Aspects of Your Prescribed Medications

Device Identifies Specific Details of Your Prescribed Drugs

In the ever-evolving world of healthcare, a device named LinkSquare is making waves as a potential game-changer. This innovative tool, developed by startup company Stratio, is designed to safeguard against prescription confusion and detect counterfeit drugs.

The device, resembling a large pencil, is held against a pill, and its companion iOS app is used to initiate the scanning process. The technology behind LinkSquare is intricate yet straightforward: it uses spectroscopy to identify drugs by detecting the wavelengths absorbed and reflected. This makes it more powerful and consistent than the human eye, capable of notating the slightest differences in hues.

LinkSquare's usefulness extends beyond pharmacies, reaching into areas with limited resources where accurate medication could be crucial, especially for diseases like malaria. The device's ability to distinguish real malaria pills from counterfeit ones could potentially save lives.

The expanded databases that power LinkSquare contribute to its price increases. The bigger the database required for identification, the higher the cost. However, the exact starting price of the LinkSquare device is not readily available and may vary depending on the vendor, model, and features. For detailed and current information on LinkSquare's device functionality and pricing, it is recommended to check the official LinkSquare website or contact authorized distributors directly.

It is estimated that as many as 50 million prescriptions are incorrectly filled each year, partially due to pill confusion. LinkSquare, with its ability to accurately identify drugs, could play a significant role in reducing these errors, saving time and energy for busy pharmacists and potentially being crucial to doctors in areas with limited resources.

Stratio, the company behind LinkSquare, was founded by four Stanford electrical engineers in 2013. Since then, they have raised over $5 million in funding, a testament to the potential impact of their innovative device.

In conclusion, LinkSquare is a promising tool in the fight against prescription errors and counterfeit medications. While the exact cost and other specific details may vary, its potential benefits make it an exciting development in the field of healthcare technology.

  1. The innovation in robotics and science, exemplified by the LinkSquare device, has the potential to revolutionize the health-and-wellness sector, particularly in detecting counterfeit drugs and reducing prescription errors.
  2. With its roots in spectroscopy and electrical engineering, the LinkSquare device – developed by Stratio – is a emblematic example of scientific innovation and an intriguing addition to the ever-evolving landscape of health-and-wellness technology.

Read also:

    Latest